Literature DB >> 9520985

Benign lesions of the liver.

P J Mergo1, P R Ros.   

Abstract

Although many hepatic lesions can overlap significantly in their imaging appearance, an imaging approach that is based upon identifying the pathologic and functional components of a lesion can aid in distinction from other entities. In this manner, the diagnostic evaluation can be tailored using the appropriate imaging modality for the lesion at hand. An understanding of the benign liver lesions based on the cellular line of origin and subsequent functional components aids in grasping their expected imaging appearance and may aid in their distinction from malignant tumors. Thus, an imaging approach leading to diagnosis of these tumors should be based on this underlying knowledge of the functional components and cells within the lesion to be studied. For lesions with Kupffer's cell activity, such as FNA, Tc-99m sulfur colloid scan or MR imaging with SPIO may yield the most diagnostic information. For lesions such as hepatic cysts or angiomyolipoma, the diagnosis is usually not a dilemma. For hemangiomas, the most commonly encountered benign hepatic lesion, distinction from other entities may be readily apparent from the initial CT scan or US examination, or it may require additional evaluation with MR imaging. Finally, for other lesions with many cellular components, such as HCA, the imaging findings may not be specific enough by any modality to preclude tissue diagnosis. In any case, it is important to know the diagnostic accuracy and limitations of the imaging modalities available for assessment of any given benign hepatic mass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520985     DOI: 10.1016/s0033-8389(05)70025-7

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  21 in total

1.  Hepatic angiomyolipoma-misdiagnosis as hepatocellular carcinoma: A report of 14 cases.

Authors:  Ding-Rong Zhong; Xiao-Long Ji
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla; Adelfio Elio Cardinale
Journal:  Eur Radiol       Date:  2005-02-15       Impact factor: 5.315

3.  Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2004-12-21       Impact factor: 5.315

Review 4.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

5.  Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization.

Authors:  Sawako Kobayashi; Hiroki Sakaguchi; Masaki Takatsuka; Takehisa Suekane; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada
Journal:  Hepatol Int       Date:  2009-03-05       Impact factor: 6.047

Review 6.  [Diagnostic imaging of liver tumours. Current status].

Authors:  B Boozari; J Lotz; M Galanski; M Gebel
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

7.  Benign Neoplasms of the Liver.

Authors:  Michael K. Porayko; Cuckoo Choudhary
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

Review 8.  Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions.

Authors:  Stanislas-H Morin; Adrian-Kp Lim; Jeremy-Fl Cobbold; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

9.  Surgical management of hepatic hemangiomas: a multi-institutional experience.

Authors:  John T Miura; Albert Amini; Ryan Schmocker; Shawnn Nichols; Daniel Sukato; Emily R Winslow; Gaya Spolverato; Aslam Ejaz; Malcolm H Squires; David A Kooby; Shishir K Maithel; Aijun Li; Meng-Chao Wu; Juan M Sarmiento; Mark Bloomston; Kathleen K Christians; Fabian M Johnston; Susan Tsai; Kiran K Turaga; Allan Tsung; Timothy M Pawlik; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2014-06-19       Impact factor: 3.647

10.  Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis.

Authors:  Chuan-Yuan Hsu; Cheng-Hsin Chu; Shee-Chan Lin; Fee-Shih Yang; Tsen-Long Yang; Kuo-Ming Chang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.